Letrozole Tablets IP 2.5mg | Letero - Hetero Oncology

Advanced Targeted Oncology & Hormone Therapy

When addressing specific hormone-receptor-positive oncology conditions, healthcare providers and patients require treatments that deliver highly precise, targeted, and reliable results. The Letrozole Tablets IP (commercially recognized as Letero) provide a potent, targeted oral therapy designed to lower estrogen levels and support critical long-term treatment plans. Manufactured by Hetero Healthcare Limited under their specialized Oncology division, these film-coated tablets ensure the steady clinical performance necessary for individuals navigating advanced health challenges.

Why Choose Letero for Clinical Management?

Managing intensive oncology conditions requires strict daily protocol adherence. Letero is an aromatase inhibitor that offers a highly effective oral formulation, empowering patients to maintain consistent, reliable treatment regimens from the comfort of their own homes without relying solely on invasive clinical visits. Hetero is a globally trusted pioneer in pharmaceutical manufacturing, providing the built-in trust, stringent quality control, and proven efficacy that oncologists, cancer institutions, and specialized pharmacies demand.

Key Product Specifications & Clinical Benefits

Targeted Active Ingredient: Contains premium-grade Letrozole IP (2.5 mg per tablet), a highly effective oral anti-estrogen therapy clinically designed to inhibit the aromatase enzyme.

Patient-Friendly Formulation: Designed as a smooth, film-coated yellow tablet to mask bitter tastes and make daily oral administration significantly easier for patients to swallow and tolerate.

Optimized Packaging: Conveniently packaged in a 10-tablet blister pack configuration, ensuring individual doses remain completely hygienic and protected from environmental degradation until the exact moment of consumption.

Streamlined Care: Oral administration significantly improves patient comfort and compliance during long-term maintenance therapy.

Essential Storage & Usage Guidelines

Protecting the integrity of this specialized medication is vital for its clinical efficacy. Store the tablets at a temperature not exceeding 30°C, and protect them strictly from light and moisture.

Important Notice: Letero is a Schedule H Prescription Drug. Caution: It is dangerous to take this preparation except under medical supervision. Warning: To be sold against demand from Hospitals / Cancer Institutions for their use and against the prescription of a Registered Medical Practitioner / Cancer Specialists only. Keep safely out of the reach of children.